TMS Therapy Cost in 2026: What You Actually Pay

Sticker shock is doing a lot of unnecessary damage here: TMS therapy can look like a five-figure expense on paper, but the number most people actually pay looks very different once insurance and Medicare rules enter the picture.

What This Article Covers

• What TMS actually costs per session, based on peer-reviewed cost modeling
• Why a full course adds up the way it does, and what drives clinic-to-clinic price differences
• What insurance and Medicare require before they’ll cover it
• What out-of-pocket cost actually looks like once coverage kicks in
• Whether TMS is cost-effective compared to continuing to cycle through medications
• Frequently asked questions about billing, coverage, and eligibility

Transcranial magnetic stimulation uses a magnetic coil placed against the scalp to deliver pulses that stimulate the brain regions involved in mood regulation, regions that tend to show decreased activity in depression, according to Mayo Clinic. It’s noninvasive, doesn’t require anesthesia, and has been available in the United States since the FDA cleared the first device, NeuroStar, in 2008 for adults with major depressive disorder who hadn’t improved on a prior antidepressant, according to the original FDA clearance decision. That history matters for cost, because a treatment this well established has had time to build the insurance infrastructure that newer neuromodulation options haven’t.

What a Session Actually Costs

A frequently cited peer-reviewed cost-effectiveness analysis modeled TMS treatment at $300 per session when comparing it to sham treatment and to standard antidepressant care. That figure came out of a real multicenter study of 301 patients and has held up as a reasonable planning number in the years since, even as protocols have evolved.

Treatment itself isn’t a single visit. Mayo Clinic describes a standard course as sessions delivered five days a week for 4 to 6 weeks, and the FDA’s original clearance documentation for NeuroStar describes a similar cadence in its pivotal trial. Using the $300 figure across a course of 20 to 36 sessions puts the pre-insurance total somewhere between $6,000 and $10,800. That’s a calculation, not a quote: your actual clinic’s rate, your protocol, and your geographic market will move that number in either direction.

Why the Bill Is Structured the Way It Is

Part of why pricing looks inconsistent from one clinic’s website to the next comes down to billing mechanics. TMS uses one procedure code for the initial session, which bundles in cortical mapping and motor threshold determination, and a separate, repeatable code for every session after that, per Medicare’s billing and coding guidance for TMS. The initial session is more involved clinically, since it establishes where on your head the coil goes and how much stimulation you need, and that’s reflected in how it’s billed separately from the daily maintenance sessions that follow.

What Insurance Actually Requires

Coverage isn’t automatic just because a diagnosis fits. Medicare’s local coverage determination for TMS lays out specific documentation requirements tied to particular diagnosis codes before a claim will be paid, and Mayo Clinic notes that most policies cover rTMS for depression but require medical necessity conditions to be met first, commonly a minimum number of antidepressants that were tried and didn’t work. Professional guidance points in the same direction: a peer-reviewed consensus statement on the clinical application of rTMS for depression concluded that rTMS is an appropriate treatment for patients with major depressive disorder even when they are medication-resistant or have significant comorbid anxiety, which is the clinical rationale insurers lean on when they set a failed-medication threshold rather than covering TMS as a first-line option.

In practice, that means your prescriber’s documentation has to show which antidepressants you took, at what dose, for how long, and why they weren’t enough, before anyone submits for authorization. Skipping that groundwork is one of the more common reasons authorization gets delayed.

What You Actually Pay After Coverage

This is where the math changes the most. Under Original Medicare, Part B applies its standard structure: an annual deductible of $283 in 2026, after which Medicare pays 80% of the approved amount and the beneficiary is responsible for the remaining 20% coinsurance, unless a supplemental Medigap policy covers that share. Applied to a $300 session rate, that 20% works out to roughly $60 per session in coinsurance once the deductible is met, meaningfully lower than paying full price out of pocket. Private insurance structures vary by plan, with their own deductibles, copays, and coinsurance percentages, so the same logic applies but the exact numbers depend on your specific policy.

Is TMS Worth the Cost Compared to Staying on Medication?

The honest answer, based on the health economics literature, is that it often compares favorably once you look past the initial price tag. A lifetime Markov modeling study comparing rTMS to continued antidepressant trials after a single failed medication found rTMS was the dominant strategy across every age range studied, meaning it produced better quality-of-life outcomes at a lower overall lifetime cost. Separately, the 2009 cost-effectiveness analysis found TMS fell well under the standard $50,000-per-QALY willingness-to-pay threshold used in health economics to judge whether a treatment is worth its cost.

None of that means TMS works for everyone or that cost-effectiveness on paper erases a real bill in your mailbox. It does mean the upfront number isn’t the whole financial story, and it’s worth asking your care team to walk through both the near-term cost and what happens if medication alone hasn’t been working.

Cost Snapshot

Because the terminology (session, course, coinsurance, deductible) gets confusing fast, here’s how the pieces fit together.

Cost Component	What It Covers	Where the Number Comes From
Per-session rate	One TMS treatment visit	Modeled at $300/session in peer-reviewed analysis
Full course	20 to 36 sessions over 4 to 6 weeks	Calculated from per-session rate and typical course length
Medicare deductible	Annual Part B deductible before coverage applies	$283 in 2026, per CMS
Medicare coinsurance	Your share after the deductible is met	20% of the approved amount, per CMS

This is a planning framework, not a bill. Confirm your own clinic’s rates and your specific insurance plan’s cost-sharing structure before starting treatment.

About SiggyMD

SiggyMD’s current clinical scope covers SSRIs, anxiety, and depression, with every treatment plan reviewed and approved by a licensed prescriber before anything moves forward. TMS itself sits outside that scope today, but the question that usually comes before someone looks into TMS, whether an antidepressant trial has actually been given a fair chance, at the right dose, for long enough, is exactly the kind of adherence and follow-up gap SiggyMD was built to close. An anonymous intake conversation gathers your history, a prescriber reviews it, and support continues between visits instead of only at the next scheduled appointment, so if medication hasn’t been working, that gets caught and addressed rather than discovered months later at a specialist referral.

Ready to Get a Clearer Picture of Your Treatment Options?

TMS can be a genuinely cost-effective option for treatment-resistant depression, but it’s typically a later step, one that insurers expect to follow a documented, fair trial of antidepressant medication first. If you’re not sure whether your current medication has actually been given that fair trial, that’s worth sorting out before anything else. An anonymous intake with SiggyMD starts with no login, no name, and no email, and every treatment plan is reviewed by a licensed prescriber before you receive it.

Ready to take control of your mental health? Get started with SiggyMD today.